Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medical Hemostatic Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3930874
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
According to our (Global Info Research) latest study, the global Medical Hemostatic Agents market size was valued at US$ 3812 million in 2023 and is forecast to a readjusted size of USD 5442 million by 2030 with a CAGR of 5.3% during review period.
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
This report is a detailed and comprehensive analysis for global Medical Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Medical Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Medical Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Medical Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Medical Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Hemostatic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Hemostatic Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Hemostatic Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gelation Hemostats
Combination Hemostats
Others
Market segment by Application
Hospitals
Surgical Centers
Others
Major players covered
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Hemostatic Agents, with price, sales quantity, revenue, and global market share of Medical Hemostatic Agents from 2019 to 2024.
Chapter 3, the Medical Hemostatic Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Hemostatic Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Hemostatic Agents.
Chapter 14 and 15, to describe Medical Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Hemostatic Agents Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Gelation Hemostats
    • 1.3.3 Combination Hemostats
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Hemostatic Agents Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Surgical Centers
    • 1.4.4 Others
  • 1.5 Global Medical Hemostatic Agents Market Size & Forecast
    • 1.5.1 Global Medical Hemostatic Agents Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Medical Hemostatic Agents Sales Quantity (2019-2030)
    • 1.5.3 Global Medical Hemostatic Agents Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 J&J
    • 2.1.1 J&J Details
    • 2.1.2 J&J Major Business
    • 2.1.3 J&J Medical Hemostatic Agents Product and Services
    • 2.1.4 J&J Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 J&J Recent Developments/Updates
  • 2.2 Baxter
    • 2.2.1 Baxter Details
    • 2.2.2 Baxter Major Business
    • 2.2.3 Baxter Medical Hemostatic Agents Product and Services
    • 2.2.4 Baxter Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Baxter Recent Developments/Updates
  • 2.3 BD
    • 2.3.1 BD Details
    • 2.3.2 BD Major Business
    • 2.3.3 BD Medical Hemostatic Agents Product and Services
    • 2.3.4 BD Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 BD Recent Developments/Updates
  • 2.4 Gelita
    • 2.4.1 Gelita Details
    • 2.4.2 Gelita Major Business
    • 2.4.3 Gelita Medical Hemostatic Agents Product and Services
    • 2.4.4 Gelita Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Gelita Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Medical Hemostatic Agents Product and Services
    • 2.5.4 Pfizer Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 B Braun
    • 2.6.1 B Braun Details
    • 2.6.2 B Braun Major Business
    • 2.6.3 B Braun Medical Hemostatic Agents Product and Services
    • 2.6.4 B Braun Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 B Braun Recent Developments/Updates
  • 2.7 CSL Behring
    • 2.7.1 CSL Behring Details
    • 2.7.2 CSL Behring Major Business
    • 2.7.3 CSL Behring Medical Hemostatic Agents Product and Services
    • 2.7.4 CSL Behring Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 CSL Behring Recent Developments/Updates
  • 2.8 Ferrosan Medical Devices
    • 2.8.1 Ferrosan Medical Devices Details
    • 2.8.2 Ferrosan Medical Devices Major Business
    • 2.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Product and Services
    • 2.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Ferrosan Medical Devices Recent Developments/Updates
  • 2.9 Advance Medical Solution
    • 2.9.1 Advance Medical Solution Details
    • 2.9.2 Advance Medical Solution Major Business
    • 2.9.3 Advance Medical Solution Medical Hemostatic Agents Product and Services
    • 2.9.4 Advance Medical Solution Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Advance Medical Solution Recent Developments/Updates
  • 2.10 Medtronic
    • 2.10.1 Medtronic Details
    • 2.10.2 Medtronic Major Business
    • 2.10.3 Medtronic Medical Hemostatic Agents Product and Services
    • 2.10.4 Medtronic Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Medtronic Recent Developments/Updates
  • 2.11 Z-Medica
    • 2.11.1 Z-Medica Details
    • 2.11.2 Z-Medica Major Business
    • 2.11.3 Z-Medica Medical Hemostatic Agents Product and Services
    • 2.11.4 Z-Medica Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Z-Medica Recent Developments/Updates
  • 2.12 Marine Polymer
    • 2.12.1 Marine Polymer Details
    • 2.12.2 Marine Polymer Major Business
    • 2.12.3 Marine Polymer Medical Hemostatic Agents Product and Services
    • 2.12.4 Marine Polymer Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Marine Polymer Recent Developments/Updates
  • 2.13 Equimedical
    • 2.13.1 Equimedical Details
    • 2.13.2 Equimedical Major Business
    • 2.13.3 Equimedical Medical Hemostatic Agents Product and Services
    • 2.13.4 Equimedical Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Equimedical Recent Developments/Updates
  • 2.14 CryoLife
    • 2.14.1 CryoLife Details
    • 2.14.2 CryoLife Major Business
    • 2.14.3 CryoLife Medical Hemostatic Agents Product and Services
    • 2.14.4 CryoLife Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 CryoLife Recent Developments/Updates

3 Competitive Environment: Medical Hemostatic Agents by Manufacturer

  • 3.1 Global Medical Hemostatic Agents Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Medical Hemostatic Agents Revenue by Manufacturer (2019-2024)
  • 3.3 Global Medical Hemostatic Agents Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Medical Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Medical Hemostatic Agents Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Medical Hemostatic Agents Manufacturer Market Share in 2023
  • 3.5 Medical Hemostatic Agents Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Hemostatic Agents Market: Region Footprint
    • 3.5.2 Medical Hemostatic Agents Market: Company Product Type Footprint
    • 3.5.3 Medical Hemostatic Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Hemostatic Agents Market Size by Region
    • 4.1.1 Global Medical Hemostatic Agents Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Medical Hemostatic Agents Consumption Value by Region (2019-2030)
    • 4.1.3 Global Medical Hemostatic Agents Average Price by Region (2019-2030)
  • 4.2 North America Medical Hemostatic Agents Consumption Value (2019-2030)
  • 4.3 Europe Medical Hemostatic Agents Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Medical Hemostatic Agents Consumption Value (2019-2030)
  • 4.5 South America Medical Hemostatic Agents Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Medical Hemostatic Agents Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 5.2 Global Medical Hemostatic Agents Consumption Value by Type (2019-2030)
  • 5.3 Global Medical Hemostatic Agents Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 6.2 Global Medical Hemostatic Agents Consumption Value by Application (2019-2030)
  • 6.3 Global Medical Hemostatic Agents Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 7.2 North America Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 7.3 North America Medical Hemostatic Agents Market Size by Country
    • 7.3.1 North America Medical Hemostatic Agents Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Medical Hemostatic Agents Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 8.2 Europe Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 8.3 Europe Medical Hemostatic Agents Market Size by Country
    • 8.3.1 Europe Medical Hemostatic Agents Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Medical Hemostatic Agents Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Medical Hemostatic Agents Market Size by Region
    • 9.3.1 Asia-Pacific Medical Hemostatic Agents Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Medical Hemostatic Agents Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 10.2 South America Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 10.3 South America Medical Hemostatic Agents Market Size by Country
    • 10.3.1 South America Medical Hemostatic Agents Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Medical Hemostatic Agents Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Medical Hemostatic Agents Market Size by Country
    • 11.3.1 Middle East & Africa Medical Hemostatic Agents Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Medical Hemostatic Agents Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Medical Hemostatic Agents Market Drivers
  • 12.2 Medical Hemostatic Agents Market Restraints
  • 12.3 Medical Hemostatic Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Hemostatic Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Hemostatic Agents
  • 13.3 Medical Hemostatic Agents Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Hemostatic Agents Typical Distributors
  • 14.3 Medical Hemostatic Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Hemostatic Agents. Industry analysis & Market Report on Medical Hemostatic Agents is a syndicated market report, published as Global Medical Hemostatic Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Medical Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,683.08
    		4,024.62
    		5,366.16
    		3,222.48
    		4,833.72
    		6,444.96
    		533,275.20
    		799,912.80
    		1,066,550.40
    		293,468.40
    		440,202.60
    		586,936.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo